Tusié Luna María Teresa
Unidad de Biología Molecular y Medicina Genómica del Instituto de Investigaciones Biomédicas de la UNAM y Nutrición Salvador Zubirán, Mexico City, Mexico DF.
Arch Med Res. 2005 May-Jun;36(3):210-22. doi: 10.1016/j.arcmed.2005.03.004.
Type 2 diabetes (T2DM) comprises a group of entities with different genetic causes. In most patients, T2DM results from alterations of various genes, each having a partial and additive effect. The inheritance pattern is thus complex, and environmental factors play an important role in favoring or delaying the expression of the disease. The identification of susceptibility genes and genetic variants requires different methodological approaches. Here we address some of the most important strategies and findings on the genomic basis of T2DM, as well as evidence of genetic heterogeneity among populations. The identification of the underlying genetic causes of T2DM and other related traits such as obesity and hypertension will lead to the development of new therapeutic targets likely to impact the way we treat these diseases. Survival and quality of life for T2DM patients is expected to eventually increase, significantly lessening the socioeconomic burden of the disease.
2型糖尿病(T2DM)包含一组具有不同遗传病因的病症。在大多数患者中,T2DM是由各种基因的改变引起的,每个基因都有部分累加效应。因此,遗传模式很复杂,环境因素在促进或延缓疾病表达方面起着重要作用。易感性基因和遗传变异的鉴定需要不同的方法。在此,我们阐述了一些关于T2DM基因组基础的最重要策略和发现,以及不同人群间遗传异质性的证据。T2DM及其他相关特征(如肥胖和高血压)潜在遗传病因的鉴定将促成新治疗靶点的开发,可能会影响我们治疗这些疾病的方式。预计T2DM患者的生存率和生活质量最终会提高,从而显著减轻该疾病的社会经济负担。